People with depression are lacking a single molecule, scientists discover
Acetyl-L-carnitine has long been recognized as important for metabolism of fatty acids in mitochondria. Its newly discovered link to depression could one day change the lives of millions.
A new study published in PNAS has uncovered a critical biomarker of depression and a promising treatment method based on the body's levels of a single molecule called acetyl-L-carnitine (ALC). This molecule's main job is to help transport fatty acids into mitochondria; in effect, it helps provide cells with energy. By comparing the blood levels of 71 depressed individuals and 45 healthy individuals, it was discovered that ALC levels were significantly lower in those suffering from depression. Not only that, but the more depressed the individual was, the lower their ALC levels.
Depression affects nearly 10% of the population at a given time, and one in four adults will experience a major depressive episode at some point in their lifetime. Although sadness is a major symptom of depression, it's not the only way that it manifests. Rather, depression is a pervasive and persistent experience of symptoms such as a loss of energy, difficulty thinking, a loss of interest in previously pleasurable activities, as well as a sense of sadness.
Of the 71 depressed individuals in the study, 43 were diagnosed with severe depression. Interestingly, these severely depressed individuals had the lowest ALC levels and were more likely to have treatment-resistant depression, to have undergone childhood trauma or abuse, and to be women (likely because depression occurs more often in women than men).
According to the researchers, about 25–30% of all depression sufferers have this type of severe depression. Because ALC levels correlated with the presence and severity of the patients' depression, measuring ALC in the blood can help psychiatrists determine who is at the greatest risk and help develop a treatment plan. In fact, providing ALC supplements to depressed patients might represent a critical treatment method.
A potentially powerful treatment
Medication is available for depression but doesn't work for everyone, and antidepressants can lose their efficacy over time. When they do work, they're often accompanied by symptoms that match the disease for discomfort: nausea, weight gain, a loss of sexual desire, anxiety, and other crummy states of being.
Acetyl-L-carnitine has long been recognized as important for metabolism of fatty acids in mitochondria. Its newly discovered link to depression could one day change the lives of millions. (Image: Creative Commons/Big Think)
But evidence exists that ALC supplementation could be a simple and effective way to treat depression. Carla Nasca, the lead author of the study, previously conducted studies on rodents with low ALC levels and depression. Of course, you can't ask a rat whether they've experienced a loss in their sense of purpose in life, but you can evaluate whether they have depressive-like symptoms, like sleep disruptions; anxious behavior; changes in weight; and changes in the density and function of their hippocampi, amygdalae, and other neural structures affected by depression.
In rodents experiencing depressive-like symptoms, supplementing them with ALC rapidly addressed their symptoms and ameliorated the dysfunction of key, depression-related brain structures. What's more, ALC did all of this within a matter of days, while most antidepressant medication can take weeks to kick in.
According to Dr. Nasca's studies, ALC supplementation would work in depressed individuals by regulating the expression of genes related to synaptic plasticity. Essentially, these genes produce molecules that help the brain strengthen, weaken, and generate new synapses. Depressed individuals aren't able to do this as well as others, causing critical mood-regulating regions in their brain to perform poorly. By regulating these genes, the neural dysfunction normally seen in depression improved.
Unfortunately, it remains to be seen whether ALC supplementation will have the same drastic effects in humans as it did in rats. Subtle genetic differences can have vastly different effects across species, and it remains to be seen how exactly ALC will work in human beings.
On this note, the researchers said, “We've identified an important new biomarker of major depression disorder. We didn't test whether supplementing with that substance could actually improve patients' symptoms. What's the appropriate dose, frequency, duration? We need to answer many questions before proceeding with recommendations, yet. This is the first step toward developing that knowledge, which will require large-scale, carefully controlled clinical trials."
The achievement of this study was in identifying that ALC levels are low in human beings, just as in rats. While this is a major milestone toward finding an effective treatment for depression, questions remain as to whether supplementation can help treat this deadly disease, whether ALC levels are low in at-risk but non-depressive patients, if it is a biomarker for depression only or for other affective disorders as well, and many more.'
Pay attention to the decisions made by the provinces.
- China leads the world in numerous green energy categories.
- CO2 emissions in the country totaling more than all coal emissions in the U.S. have recently emerged.
- This seems to be an administrative-induced blip on the way towards a green energy tipping point.
NASA astronomer Michelle Thaller is coming back to Big Think to answer YOUR questions! Here's all you need to know to submit your science-related inquiries.
Big Think's amazing audience has responded so well to our videos from NASA astronomer and Assistant Director for Science Communication Michelle Thaller that we couldn't wait to bring her back for more!
And this time, she's ready to tackle any questions you're willing to throw at her, like, "How big is the Universe?", "Am I really made of stars?" or, "How long until Elon Musk starts a colony on Mars?"
All you have to do is submit your questions to the form below, and we'll use them for an upcoming Q+A session with Michelle. You know what to do, Big Thinkers!
Or how I learned to stop worrying and love my tsundoku.
- Many readers buy books with every intention of reading them only to let them linger on the shelf.
- Statistician Nassim Nicholas Taleb believes surrounding ourselves with unread books enriches our lives as they remind us of all we don't know.
- The Japanese call this practice tsundoku, and it may provide lasting benefits.
Calling all big thinkers!
The Boring Company plans to offer free rides in its prototype tunnel in Hawthorne, California in December.
- The prototype tunnel is about 2 miles long and contains electric skates that travel at top speeds of around 150 mph.
- This is the first tunnel from the company that will be open to the public.
- If successful, the prototype could help the company receive regulatory approval for much bigger projects in L.A. and beyond.
Money makes the world go 'round. Unfortunately, it can make both children and adults into materialists.
- Keeping a gratitude journal caused children to donate 60 percent more to charitable causes.
- Other methods suggested by researchers include daily gratitude reflection, gratitude posters, and keeping a "gratitude jar."
- Materialism has been shown to increase anxiety and depression and promote selfish attitudes and behavior.
Anatomy and physiology professor David Harper claims a recent study in The Lancet is flawed.
- The low-carbohydrate group in a recent Lancet study were typically middle-aged, obese, sedentary, diabetic smokers.
- The study was not a randomized, controlled, double-blind experiment.
- Harper has been in ketosis for six years, and says it has profound effects on cancer patients, among other chronic ailments.
A mind-bending paradox questions the nature of reality.
- Boltzmann Brains are hypothetical disembodied entities with self-awareness.
- It may be more likely for a Boltzmann Brain to come into existence than the whole Universe.
- The idea highlights a paradox in thermodynamics.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.